Referral and evaluation for kidney transplantation among patients with lupus nephritis-related end-stage kidney disease

被引:1
|
作者
McPherson, Laura [1 ]
Plantinga, Laura C. [2 ,3 ]
Howards, Penelope P. [1 ]
Kramer, Michael [1 ]
Pastan, Stephen O. [4 ]
Patzer, Rachel E. [5 ,6 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd NE, Atlanta, GA 30312 USA
[2] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA USA
[4] Emory Univ, Dept Med, Sch Med, Atlanta, GA 30312 USA
[5] Indiana Univ Sch Med, Dept Surg, Div Transplantat, Indianapolis, IN USA
[6] Regenstrief Inst Hlth Care, Indianapolis, IN USA
关键词
Nephritis; renal lupus; systemic lupus erythematosus; RENAL-DISEASE; RACIAL DISPARITIES; US; BARRIERS; COMPLETION; POVERTY; FAILURE;
D O I
10.1177/09612033231219739
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: For the majority of patients with lupus nephritis-related end-stage kidney disease (LN-ESKD), kidney transplant is associated with better outcomes than dialysis. Access to kidney transplant requires an initial referral to a transplant center and medical evaluation prior to waitlisting. The study's objective was to examine access to these early steps in the kidney transplant process among patients with LN-ESKD.Methods: Adults who began treatment for ESKD in the Southeast, Northeast, New York, or Ohio River Valley U.S. regions from 1/1/2012 to 12/31/2019, followed through 6/30/2021, were identified from the United States Renal Data System. Referral and evaluation start data were collected from 28 of 48 transplant centers across these regions. The exposure was primary cause of ESKD (LN-ESKD vs other-ESKD). The outcomes were referral and evaluation start at a transplant center. Cox models quantified the association between LN-ESKD (vs other-ESKD) and referral and evaluation start.Results: Among 192,318 patients initiating treatment for ESKD, 0.4% had LN-ESKD. Over half (58%) of LN-ESKD patients were referred before study end, and among those referred, 66% started the evaluation. In adjusted analyses, patients with LN-ESKD were referred (HR: 1.09, 95% CI: 0.99, 1.19) and started the transplant evaluation (HR: 1.13, 95% CI: 1.00, 1.28) at a higher rate than patients with other-ESKD. Among referred patients with LN-ESKD, the median time from ESKD start to referral was 2.9 months (IQR: <1 to 11.7 months), which is similar to patients with other-ESKD (median 2.6 months, IQR: <1 to 8.8 months).Conclusions: Among incident patients with ESKD, having a primary diagnosis of LN-ESKD versus other-ESKD is associated with higher rates of early transplant access outcomes. Despite this, patients with LN-ESKD (vs other-ESKD) are less likely to be preemptively referred (i.e., referred prior to ESKD start) for kidney transplant. While providers may no longer be delaying the early steps in the kidney transplantation process among this patient population, there is still room for improvement in the rates of preemptive referral. Access to kidney transplant referral prior to ESKD could result in increased transplant rates and better transplant outcomes for patients with LN-ESKD.
引用
收藏
页码:48 / 57
页数:10
相关论文
共 50 条
  • [1] Lupus Nephritis and End-stage Kidney Disease
    Maroz, Natallia
    Segal, Mark S.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (04): : 319 - 323
  • [2] Lupus nephritis-related chronic kidney disease
    Lichtnekert, Julia
    Anders, Hans-Joachim
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2024,
  • [3] Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis
    Plantinga, Laura C.
    Patzer, Rachel E.
    Drenkard, Cristina
    Kramer, Michael R.
    Klein, Mitchel
    Lim, S. Sam
    McClellan, William M.
    Pastan, Stephen O.
    [J]. ARTHRITIS CARE & RESEARCH, 2015, 67 (04) : 571 - 581
  • [4] Interstitial fibrosis increases the risk of end-stage kidney disease in patients with lupus nephritis
    Sun, Yi-Syuan
    Huang, De-Feng
    Chang, Fu-Pang
    Chen, Wei-Sheng
    Liao, Hsien-Tzung
    Chen, Ming-Han
    Tsai, Hung-Cheng
    Tsai, Ming-Tsun
    Tsai, Chang-Youh
    Lai, Chien-Chih
    Yang, Chih-Yu
    [J]. RHEUMATOLOGY, 2024, 63 (09): : 2467 - 2472
  • [5] Long-term outcomes of end-stage kidney disease for patients with lupus nephritis
    Zhang, Lei
    Lee, Gavin
    Liu, Xusheng
    Pascoe, Elaine M.
    Badve, Sunil V.
    Boudville, Neil C.
    Clayton, Philip A.
    Hawley, Carmel M.
    Kanellis, John
    McDonald, Stephen P.
    Peh, Chen Au
    Polkinghorne, Kevan R.
    Johnson, David W.
    [J]. KIDNEY INTERNATIONAL, 2016, 89 (06) : 1337 - 1345
  • [6] Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia
    Patzer, Rachel E.
    Plantinga, Laura C.
    Paul, Sudeshna
    Gander, Jennifer
    Krisher, Jenna
    Sauls, Leighann
    Gibney, Eric M.
    Mulloy, Laura
    Pastan, Stephen O.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (06): : 582 - 594
  • [7] Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis
    Ward, MM
    [J]. KIDNEY INTERNATIONAL, 2000, 57 (05) : 2136 - 2143
  • [8] Access to renal transplantation among patients with end-stage renal disease due to lupus nephritis
    Ward, MM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 915 - 922
  • [9] Population-based Trends in Obesity and Kidney Transplantation Among Patients With End-stage Kidney Disease
    Wakam, Glenn K.
    Sheetz, Kyle H.
    Gerhardinger, Laura
    Montgomery, John R.
    Waits, Seth A.
    [J]. TRANSPLANTATION DIRECT, 2021, 7 (12): : E787
  • [10] Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy
    Fredy Nieto-Rios, John
    Maria Serna-Higuita, Lina
    Alexandra Builes-Rodriguez, Sheila
    Cesar Restrepo-Correa, Ricardo
    Aristizabal-Alzate, Arbey
    Ocampo-Kohn, Catalina
    Serna-Campuzano, Angelica
    Cardona-Diaz, Natalia
    Dario Giraldo-Ramirez, Nelson
    Adolfo Zuluaga-Valencia, Gustavo
    [J]. COLOMBIA MEDICA, 2016, 47 (01): : 51 - 58